
Sean E. Aeder
Examiner (ID: 2139, Phone: (571)272-8787 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1939 |
| Issued Applications | 907 |
| Pending Applications | 201 |
| Abandoned Applications | 855 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7168209
[patent_doc_number] => 20050201978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Tumor and infectious disease therapeutic compositions'
[patent_app_type] => utility
[patent_app_number] => 10/991049
[patent_app_country] => US
[patent_app_date] => 2004-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20493
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20050201978.pdf
[firstpage_image] =>[orig_patent_app_number] => 10991049
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/991049 | Tumor and infectious disease therapeutic compositions | Nov 16, 2004 | Abandoned |
Array
(
[id] => 5230862
[patent_doc_number] => 20070292970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-20
[patent_title] => 'Method for Distinguishing Aml-Specific Flt3 Length Mutations From Tkd Mutations'
[patent_app_type] => utility
[patent_app_number] => 10/575600
[patent_app_country] => US
[patent_app_date] => 2004-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40976
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20070292970.pdf
[firstpage_image] =>[orig_patent_app_number] => 10575600
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/575600 | Method for Distinguishing Aml-Specific Flt3 Length Mutations From Tkd Mutations | Nov 3, 2004 | Abandoned |
Array
(
[id] => 5259102
[patent_doc_number] => 20070212734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-13
[patent_title] => 'Method for Distinguishing T(11Q23)/Mll-Positive Leukemias From t(11Q23)/Mll Negative Leukemia'
[patent_app_type] => utility
[patent_app_number] => 10/575805
[patent_app_country] => US
[patent_app_date] => 2004-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19022
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20070212734.pdf
[firstpage_image] =>[orig_patent_app_number] => 10575805
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/575805 | Method for Distinguishing T(11Q23)/Mll-Positive Leukemias From t(11Q23)/Mll Negative Leukemia | Nov 3, 2004 | Abandoned |
Array
(
[id] => 132258
[patent_doc_number] => 07695899
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-13
[patent_title] => 'Methods of identifying and using chemotherapeutic agents'
[patent_app_type] => utility
[patent_app_number] => 10/978206
[patent_app_country] => US
[patent_app_date] => 2004-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8228
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/695/07695899.pdf
[firstpage_image] =>[orig_patent_app_number] => 10978206
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/978206 | Methods of identifying and using chemotherapeutic agents | Oct 28, 2004 | Issued |
Array
(
[id] => 860087
[patent_doc_number] => 07371527
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-05-13
[patent_title] => 'Hypermethylation of GATA-4 and GATA-5 transcription factor genes in cancer'
[patent_app_type] => utility
[patent_app_number] => 10/972066
[patent_app_country] => US
[patent_app_date] => 2004-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 13
[patent_no_of_words] => 25425
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/371/07371527.pdf
[firstpage_image] =>[orig_patent_app_number] => 10972066
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/972066 | Hypermethylation of GATA-4 and GATA-5 transcription factor genes in cancer | Oct 20, 2004 | Issued |
Array
(
[id] => 314664
[patent_doc_number] => 07524634
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-28
[patent_title] => 'MN/CA IX and cancer prognosis'
[patent_app_type] => utility
[patent_app_number] => 10/575300
[patent_app_country] => US
[patent_app_date] => 2004-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 17
[patent_no_of_words] => 13890
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 205
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/524/07524634.pdf
[firstpage_image] =>[orig_patent_app_number] => 10575300
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/575300 | MN/CA IX and cancer prognosis | Oct 17, 2004 | Issued |
Array
(
[id] => 5716081
[patent_doc_number] => 20060079444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-13
[patent_title] => 'Human Sef isoforms and methods of using same for cancer gene therapy'
[patent_app_type] => utility
[patent_app_number] => 10/963439
[patent_app_country] => US
[patent_app_date] => 2004-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 18310
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20060079444.pdf
[firstpage_image] =>[orig_patent_app_number] => 10963439
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/963439 | Human Sef isoforms and methods of using same for cancer gene therapy | Oct 10, 2004 | Abandoned |
Array
(
[id] => 7773539
[patent_doc_number] => 08119340
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-21
[patent_title] => 'Methods and compositions for diagnosis and treatment of B cell chronic lymphocytic leukemia'
[patent_app_type] => utility
[patent_app_number] => 10/575671
[patent_app_country] => US
[patent_app_date] => 2004-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 15379
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 290
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/119/08119340.pdf
[firstpage_image] =>[orig_patent_app_number] => 10575671
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/575671 | Methods and compositions for diagnosis and treatment of B cell chronic lymphocytic leukemia | Oct 7, 2004 | Issued |
Array
(
[id] => 5056784
[patent_doc_number] => 20070059706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Materials and methods relating to breast cancer classification'
[patent_app_type] => utility
[patent_app_number] => 10/574392
[patent_app_country] => US
[patent_app_date] => 2004-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 26920
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20070059706.pdf
[firstpage_image] =>[orig_patent_app_number] => 10574392
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/574392 | Materials and methods relating to breast cancer classification | Sep 30, 2004 | Abandoned |
Array
(
[id] => 6939080
[patent_doc_number] => 20050112643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Atr-2 cell cycle checkpoint'
[patent_app_type] => utility
[patent_app_number] => 10/954723
[patent_app_country] => US
[patent_app_date] => 2004-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20105
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112643.pdf
[firstpage_image] =>[orig_patent_app_number] => 10954723
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/954723 | Atr-2 cell cycle checkpoint | Sep 29, 2004 | Abandoned |
Array
(
[id] => 307234
[patent_doc_number] => 07531300
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-12
[patent_title] => 'Method of diagnosing breast cancer'
[patent_app_type] => utility
[patent_app_number] => 10/573297
[patent_app_country] => US
[patent_app_date] => 2004-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 36366
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/531/07531300.pdf
[firstpage_image] =>[orig_patent_app_number] => 10573297
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/573297 | Method of diagnosing breast cancer | Sep 23, 2004 | Issued |
Array
(
[id] => 6944360
[patent_doc_number] => 20050196409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-08
[patent_title] => 'Compositions of botanical extracts for treating malignancy-associated changes'
[patent_app_type] => utility
[patent_app_number] => 10/949178
[patent_app_country] => US
[patent_app_date] => 2004-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 14962
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20050196409.pdf
[firstpage_image] =>[orig_patent_app_number] => 10949178
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/949178 | Compositions of botanical extracts for treating malignancy-associated changes | Sep 23, 2004 | Abandoned |
Array
(
[id] => 848894
[patent_doc_number] => 07381410
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-06-03
[patent_title] => 'Polypeptide compounds for inhibiting angiogenesis and tumor growth'
[patent_app_type] => utility
[patent_app_number] => 10/949720
[patent_app_country] => US
[patent_app_date] => 2004-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 110
[patent_figures_cnt] => 135
[patent_no_of_words] => 51197
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/381/07381410.pdf
[firstpage_image] =>[orig_patent_app_number] => 10949720
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/949720 | Polypeptide compounds for inhibiting angiogenesis and tumor growth | Sep 22, 2004 | Issued |
Array
(
[id] => 7075264
[patent_doc_number] => 20050148532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => '14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types'
[patent_app_type] => utility
[patent_app_number] => 10/938387
[patent_app_country] => US
[patent_app_date] => 2004-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 25977
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20050148532.pdf
[firstpage_image] =>[orig_patent_app_number] => 10938387
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/938387 | 14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types | Sep 9, 2004 | Issued |
Array
(
[id] => 7216748
[patent_doc_number] => 20050054665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Treatment for CD5+ B cell lymphoma'
[patent_app_type] => utility
[patent_app_number] => 10/933594
[patent_app_country] => US
[patent_app_date] => 2004-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10864
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054665.pdf
[firstpage_image] =>[orig_patent_app_number] => 10933594
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/933594 | Treatment for CD5+ B cell lymphoma | Sep 2, 2004 | Abandoned |
Array
(
[id] => 7018762
[patent_doc_number] => 20050220781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'IFIX, a novel HIN-200 protein, for cancer therapy'
[patent_app_type] => utility
[patent_app_number] => 10/934861
[patent_app_country] => US
[patent_app_date] => 2004-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 40418
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20050220781.pdf
[firstpage_image] =>[orig_patent_app_number] => 10934861
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/934861 | IFIX, a novel HIN-200 protein, for cancer therapy | Sep 2, 2004 | Abandoned |
Array
(
[id] => 7083241
[patent_doc_number] => 20050048621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Genetically altered antibody-producing cell lines with improved antibody characteristics'
[patent_app_type] => utility
[patent_app_number] => 10/933034
[patent_app_country] => US
[patent_app_date] => 2004-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15308
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20050048621.pdf
[firstpage_image] =>[orig_patent_app_number] => 10933034
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/933034 | Genetically altered antibody-producing cell lines with improved antibody characteristics | Sep 1, 2004 | Issued |
Array
(
[id] => 7122360
[patent_doc_number] => 20050014189
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-20
[patent_title] => 'Reagents and methods useful for detecting diseases of the gastrointestinal tract'
[patent_app_type] => utility
[patent_app_number] => 10/926217
[patent_app_country] => US
[patent_app_date] => 2004-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 36528
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20050014189.pdf
[firstpage_image] =>[orig_patent_app_number] => 10926217
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/926217 | Reagents and methods useful for detecting diseases of the gastrointestinal tract | Aug 24, 2004 | Abandoned |
Array
(
[id] => 7083209
[patent_doc_number] => 20050048589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Lung cancer specific gene products: their coding sequence, their antibodies and their use in diagnostic, therapeutic and disease management of lung cancer'
[patent_app_type] => utility
[patent_app_number] => 10/926543
[patent_app_country] => US
[patent_app_date] => 2004-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 60
[patent_no_of_words] => 19115
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20050048589.pdf
[firstpage_image] =>[orig_patent_app_number] => 10926543
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/926543 | Lung cancer specific gene products: their coding sequence, their antibodies and their use in diagnostic, therapeutic and disease management of lung cancer | Aug 24, 2004 | Abandoned |
Array
(
[id] => 7121987
[patent_doc_number] => 20050013816
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-20
[patent_title] => 'Modulators of the function of FAS/AP01 receptors'
[patent_app_type] => utility
[patent_app_number] => 10/923031
[patent_app_country] => US
[patent_app_date] => 2004-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17263
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20050013816.pdf
[firstpage_image] =>[orig_patent_app_number] => 10923031
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/923031 | Modulators of the function of FAS/APO1 receptors | Aug 22, 2004 | Issued |